logo
What Happens When a Pilot Gets Sick or Dies Mid-flight?

What Happens When a Pilot Gets Sick or Dies Mid-flight?

Commercial pilots may fly 900,000-pound jumbo jets with hundreds of passengers on board, but that doesn't make them superhuman. Like us, they have immune systems that sometimes falter. While it's uncommon for pilots to get sick or hurt on the job, it's not unheard of. And rarely, they pass away mid-flight. Just last year, a Turkish Airlines flight from Seattle to Istanbul was forced to make an emergency landing in New York when its 59-year-old pilot collapsed and died a few hours into the 12-hour flight. Thankfully, these unfortunate incidents seldom lead to accidents or even situations that affect passengers—here's what happens when a pilot gets sick mid-flight.
It's important to note that most sick pilots never make it onto the flight in the first place. 'This is because we assess our 'Fitness to Fly' prior to each flight,' explains Adam Cohen, a captain at SkyWest Airlines. While it's not a comprehensive guide, the FAA's pre-flight health checklist for pilots is called the IMSAFE Checklist. The letters stand for illness, medication, stress, alcohol, fatigue, and emotion. If a pilot doesn't feel 100 percent in any category, or they've been impacted by medication or alcohol consumption, they should refrain from flying and notify their doctor.
Furthermore, in order to fly commercial planes carrying more than six passengers, all pilots need a medical certificate, issued by an official Aviation Medical Examiner. This certificate ensures they're physically and mentally healthy, and it's only good for 6-12 months, depending on the pilot's age. Pilots must be seen by a doctor regularly, and they can't be morbidly obese or have substance abuse issues.
Despite the FAA and airlines' best efforts to ensure commercial pilots are healthy—they even feed them different meals to prevent the entire flight deck from suffering from food poisoning—pilots occasionally fall ill during a flight they're working. However, this doesn't necessarily mean it's a mayday situation. 'If a pilot becomes sick or incapacitated in flight, the other pilot is fully qualified to take over and safely operate the aircraft,' explains Rock Saddy, a pilot and liaison for Cirrus Aviation Services. 'Commercial flights always have at least two trained pilots on the flight deck, and in some cases, particularly long-haul routes, a relief pilot may also be on board.'
In addition to keeping passengers comfortable, flight attendants are trained to assist in medical emergencies. And according to the Centers for Disease Control and Prevention (CDC), U.S. aircrafts with one or more flight attendants on board are required to have a U.S. Food and Drug Administration-approved automated external defibrillator on board as well as a first aid kit, plus an emergency medical kit containing certain medications you wouldn't find in a first aid kit.
Saddy tells Travel + Leisure that many airlines also have 24/7 access to services such as MedLink that connect flight crews with emergency room doctors via phone, satellite, or radio. If the pilot is seriously ill, the trained doctor will instruct the pilot taking over to divert to the nearest appropriate airport so the sick pilot can receive medical attention.
Most frequent fliers can recall a time when they were on a flight and the crew asked passengers who were doctors or nurses to volunteer to assist in the event of a medical emergency. Because this happens rather frequently (although it's most often a fellow passenger, not the pilot, who needs help), the Aviation Medical Assistance Act, which passed in 1998, includes a section that protects medical personnel from being sued for providing 'good-faith' medical care in the event of an emergency.
However, this only applies to domestic flights within the U.S. It may not cover you on an international flight. And if you've been consuming alcohol, you could be liable for misconduct or negligence. Ultimately, whether or not you step forward to assist is up to you, so read up on the regulations before you travel.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

World's ‘oldest baby': what a 30-year-old embryo tells us about the future of fertility
World's ‘oldest baby': what a 30-year-old embryo tells us about the future of fertility

Yahoo

time29 minutes ago

  • Yahoo

World's ‘oldest baby': what a 30-year-old embryo tells us about the future of fertility

A baby born in the US has made headlines for a surprising reason: they came from an embryo that had been frozen for more than 30 years — setting a new world record. The embryo was created and stored in 1994, back when Bill Clinton was US president and the internet, email and mobile phones were still in their infancy. Now, decades later, that embryo has become a living child. But how is this possible – and what does it mean for the future of fertility treatment? Freezing embryos is a common and effective part of in vitro fertilisation (IVF). During IVF, multiple eggs are fertilised, and any unused embryos can be frozen and stored for future use. Globally, thousands of embryos are placed in long-term storage each year – and as the demand for fertility treatment grows, so too does the number of embryos in storage. But once a person or couple finishes treatment, the question of what to do with unused embryos can become complicated. As this case in the US illustrates, families and circumstances change. Relationships may end. People may change their minds. And yet, many feel conflicted about allowing embryos to 'perish' (the term used when frozen embryos are removed from storage, thawed and not used), especially after investing significant emotional, physical and financial resources in their creation. As a result, many continue to pay storage fees for years – sometimes decades – after their treatment has ended. Embryo donation One option for those with unused embryos is to donate them. Typically, this is coordinated through the fertility clinic. But in this record-breaking case, the embryos were donated through a US Christian organisation called Snowflakes, which allows donors to choose the recipients. The donor – now a woman in her 60s – wanted a say in where the embryos went because any resulting children would be full genetic siblings to her 30-year-old daughter. In many countries, donor-conceived people are now entitled to information about their donors. But rarely does this involve embryos frozen for decades – raising the possibility of a future connection between the child, their parents and the donor family, including a half-sibling born 30 years earlier. In the US, there's no legal limit on how long embryos (or sperm and eggs) can be stored. In the UK, the maximum storage limit was recently extended to 55 years, enabling a similar situation: someone could be conceived from an embryo stored for decades, and the donor may be elderly – or even deceased – by the time contact is made. Read more: What remains unclear is how these wide age gaps between donor and child – or between donor-conceived siblings – might affect how people relate to one another. It's an area that remains largely unexplored. Finding genetic relatives As direct-to-consumer DNA testing becomes increasingly common, more donor-conceived people are turning to services like 23andMe and to find genetic relatives outside of regulated routes. These commercial tests allow users to upload a sample and receive a list of people they may be related to, including potential donors or donor siblings. With longer embryo storage periods possible, it's likely that people will use these platforms to make contact with genetic relatives across many years, bypassing formal donor registries and regulated systems. In this US case, the embryo donation took place within the same country. But that's not always the case. With the globalisation of fertility treatment, including international travel and the cross-border shipment of frozen sperm, eggs and embryos, it's increasingly common for people who are genetically related to live in different countries. A 2024 Netflix documentary about sperm donation highlighted this issue, showing how a single donor fathered children in multiple countries, prompting calls for better regulation of international donor limits. One of the most intriguing – and underexplored – questions is how people born from decades-old embryos will come to understand their origins. While research on donor-conceived families suggests that they typically function well, the idea of being 'frozen in time' for 30 years is unique. It introduces a temporal disconnect between conception and birth that may feel uncanny or dislocating. Donor-conceived people are often curious about their genetic background – but being born from an embryo created before the internet or mobile phones adds another layer to this. It could influence how people make sense of their identity, family connections, and even their place in history, especially if their genetic siblings or donors are decades older, or deceased. The long gap between fertilisation and birth raises profound questions not just about biology, but about belonging, narrative, and what it means to be from a particular time. With rapid advances in reproductive technology, it's likely this won't be the last record-breaking case. As techniques improve and cultural boundaries around family and parenthood continue to evolve, we'll see more questions arise: about identity, genetics and what it really means to be part of a family. This article is republished from The Conversation under a Creative Commons license. Read the original article. Nicky Hudson receives funding from the UK Economic and Social Research Council. She is a member of the UK NICE Guideline Committee on fertility treatment, a working group member for the Nuffield Council on Bioethics' project on Reviewing the 14-day rule, a member of the British Fertility Society's Law, Policy and Ethics group and an advisory board member for the Fertility Alliance.

MedTech Manufacturer Juvent Joins the Inc. 5000 List of America's Fastest-Growing Private Companies
MedTech Manufacturer Juvent Joins the Inc. 5000 List of America's Fastest-Growing Private Companies

Yahoo

time29 minutes ago

  • Yahoo

MedTech Manufacturer Juvent Joins the Inc. 5000 List of America's Fastest-Growing Private Companies

With Three-Year Revenue Growth of 552%, This Marks Juvent's First Time on the List Juvent Joins Inc. 5000 The Juvent Micro-Impact Platform CHATTANOOGA, Tenn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that Juvent, makers of the Juvent Micro-Impact Platform, is in the top 15% of the prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy's most dynamic segment—its independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, and Patagonia. 'Being ranked #757 is a testament to the life-changing impact our technology has on people's health,' said Rush Simonson, Juvent Chairman & CEO. 'We're proud to assemble every unit right here in Tennessee, and even prouder to see it helping people worldwide to feel better every day. This isn't just a win for Juvent, it's a win for everyone who refuses to let pain dictate their life.' Juvent focuses on regenerative medicine, enabling the body's own systems to repair themselves and speed healing. The Juvent technology was originally developed by Jack Ryaby, the inventor of the Biomet EBI Bone Healing System and the EXOGEN Ultrasound Bone Healing System, both of which are still widely used today. The Juvent Micro-Impact Platform is an FDA-registered, Class I medical device that delivers a patented, resonant, low-magnitude, high-frequency mechanical signal through the soles of the feet while the user stands on it. This gentle technology is clinically shown to promote bone strength, improve circulation, reduce pain, and activate key cellular processes, including stimulating mesenchymal stem cell production. Just 20 minutes a day helps support overall wellness, especially for those managing chronic conditions like poor bone health, lymphedema, neuropathy, and joint pain. Since 2011, the Juvent platform has been trusted by thousands, including tennis Olympic gold medalist Mike Bryan, Baltimore Ravens linebacker Ray Lewis, and high-profile personalities like Steve Harvey to speed recovery, reduce pain, and improve daily well-being. Juvent's unique technology has also been featured on nationally recognized health platforms, including Dr. Gundry's and Dr. Drew Pinsky's podcasts. The Juvent platform has been studied by top institutions and is used in both clinical and home settings. Double-blinded, placebo-controlled clinical trials involving the Juvent platform have been conducted in collaboration with renowned organizations such as St. Jude and Harvard and featured in publications like JAMA Oncology. Unlike the common high-powered whole-body vibration platforms, Juvent stands apart through its patented, resonance-based technology. The smart device automatically determines each user's ideal resonant frequency based on hydration to deliver a personalized dosage of micro-impacts. This precision approach is key to why Juvent is safe for children, adults, and seniors—and highly effective for all ages. Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit About JuventJuvent delivers clinically validated solutions to improve musculoskeletal health. Our patented Micro-Impact Platform has clinically demonstrated the ability to help users manage and improve their musculoskeletal health noninvasively. Additionally, our technology helps users decrease joint pain and increase lymphatic drainage. Juvent's Micro-Impact is an essential ingredient for total health and vitality, a 'Vitamin of Exercise™.' Photos accompanying this announcement are available at: CONTACT: Contact: Sarah Rhodes Info@ (423) 635-7601Sign in to access your portfolio

Hand soaps, cleansers voluntarily recalled over bacteria contamination
Hand soaps, cleansers voluntarily recalled over bacteria contamination

Yahoo

time29 minutes ago

  • Yahoo

Hand soaps, cleansers voluntarily recalled over bacteria contamination

A New Jersey-based medical care and skin care products manufacturer is voluntarily recalling multiple types of hand soap, cleanser and antiseptic products due to bacteria contamination. DermaRite Industries, LLC announced a recall of its DermaKleen antiseptic lotion soap with vitamin E in 1,000-milliliter and 800-milliliter sizes, as well as KleenFoam antibacterial foam soap with aloe vera (1,000-milliliter sizes), DermaSarra external analgesic (7.5-ounce sizes), and PeriGiene antiseptic cleanser (7.5-ounce sizes), all of which were distributed in the U.S. and Puerto Rico. Impacted products have expiration dates ranging from July 2025 to February 2027. A full list of affected lot and reorder numbers can be found here. The company recall announcement, dated Aug. 8, was also shared on the U.S. Food and Drug Administration website over the weekend. DermaRite said in its announcement that the impacted products are contaminated with Burkholderia cepacia, a type of bacteria that can cause serious or life-threatening infections. "The contaminated products may be used by immunosuppressed individuals or by people attending to immunosuppressed individuals," DermaRite stated. "In healthy individuals with minor skin lesions the use of the product will more likely result in local infections, whereas in immunocompromised individuals the infection is more likely to spread into blood stream leading to life-threatening sepsis." Nearly 200,000 kids play kitchens recalled after 1 reported death The Centers for Disease Control and Prevention states that Burkholderia cepacia, also referred to as B. cepacia or Bcc, often spreads through soil and water sources, in addition to contaminated surfaces and products and through person-to-person contact. When someone is infected with the bacteria, they may not exhibit any symptoms. If they do show symptoms, they may experience respiratory issues or a fever or fatigue. High Noon voluntarily recalls some vodka seltzer drinks that were mislabeled as Celsius energy drinks People who are immunocompromised or those with chronic lung conditions including cystic fibrosis are at higher risk of becoming infected with B. cepacia, according to the CDC. The bacteria can also be resistant to antibiotics, making infections difficult to treat, the CDC states. DermaRite said it has already notified its distributors and customers via e-mail "to immediately examine available inventory" and to destroy any recalled products "in accordance with each facility's process." The company said it has not received any reports of adverse reactions in connection with the recall. Anyone experiencing symptoms after product use should consult with their health care provider and report adverse reactions to the FDA's MedWatch Adverse Event Reporting program, it added. Customers with questions or those in need of further information on the recall can contact DermaRite by phone at (973) 569-9000, extension 104, Monday through Friday from 9 a.m. to 5 p.m. EST, or via email at ABC News has reached out to DermaRite Industries for comment. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store